
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz - 2
Evaluated Smartwatches for Wellness Devotees - 3
Step by step instructions to Buy a Jeep Wrangler on a Senior's Spending plan - 4
Manhunt for Brown University shooter continues: FBI releases photos of suspect, announces $50K reward - 5
The most effective method to Pick the Right Old Consideration Administration: Key Contemplations
21 Incredibly Interesting Contemplations To Observe Consistently
Little Urban areas to Visit in Western Europe
WHO issues guidance on GLP-1 drugs for obesity
They died 'doing what they loved': The stories of workers in their 80s who died on the job
Vote In favor of Your Number one Kind Of Food Conveyance Administration
Former GLP-1 users regain lost weight after about 18 months, study says
5 Great Crossover Vehicles For Eco-friendliness In 2024
Vote in favor of your #1 Kind of Cap
Blood pressure drug recalled for possible cross-contamination












